Investor's Business Daily ad creative
Investor's Business Daily
Investor's Business Daily

Inactive· since May 8, 2026

99
days it ran
0
relaunches

Ad copy

Lilly's Next Obesity Drug Is So Powerful, Copycats Are Beating It To Market

Lilly's Next Obesity Drug Is So Powerful It's Already Getting Copied

Eli Lilly's next obesity drug, retatrutide, is so popular it's already getting copied. Can Lilly compete with its own drug?

Visit destination
🪄Crush AI

Like this ad? Make it yours.

Crush rebuilds this exact creative around your product — your brand, your colors, your offer — in about a minute.

More ads from Investor's Business Daily

Investor's Business DailyInvestor's Business Daily
Active
175 Days
-Reach
6Ads
Investor's Business Daily Facebook ad
Details
Investor's Business DailyInvestor's Business Daily
Inactive
9 Days
-Reach
1Ads
Investor's Business Daily Facebook ad
Details
Investor's Business DailyInvestor's Business Daily
Inactive
9 Days
-Reach
1Ads
Investor's Business Daily Facebook ad
Details
Investor's Business DailyInvestor's Business Daily
Active
184 Days
-Reach
1Ads
Investor's Business Daily Facebook ad
Details
Investor's Business DailyInvestor's Business Daily
Active
127 Days
-Reach
Investor's Business Daily Facebook ad
Details
Investor's Business DailyInvestor's Business Daily
Active
127 Days
-Reach
Investor's Business Daily Facebook ad
Details
Investor's Business DailyInvestor's Business Daily
Active
148 Days
-Reach
Investor's Business Daily Facebook ad
Details
Investor's Business DailyInvestor's Business Daily
Active
149 Days
-Reach
Investor's Business Daily Facebook ad
Details
Investor's Business Daily Ad — Ran 99 Days | Crush Ad Library